The global clot management market is estimated to grow at a high rate during the forecast period. A number of factors such as high prevalence of chronic diseases such as heart attacks and stroke; growing adoption of percutaneous devices instead of open surgical procedures, and increasing healthcare awareness are fuelling the growth of the global clot management market. However, dearth of trained physician and lack of reimbursement in developing countries are some of the key factors restraining the growth of global clot management market. Moreover, anticoagulation therapy remains the standard treatment for deep vein thrombosis (DVT), which is further challenging the growth of this market.
Emerging markets such as China and India offer high growth opportunities for companies engaged in the development and manufacturing of clot management devices. Increasing investments to develop healthcare facilities is expected to improve the access to clot management procedures for rural population, which would accelerate the demand for clot management devices in these emerging nations. Moreover, growing unmet medical and healthcare needs, and large pool of patients are also propelling demand for clot management devices in emerging nations.
AngioDynamics, Inc. (U.S.), Applied Medical Resources Corporation (U.S.), Bayer HealthCare AG (Germany), Boston Scientific Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), EKOS Corporation (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Medtronic, Inc. (U.S.), Stryker Corporation (U.S.), and Volcano Corporation (U.S.) are some of the key players in the global clot management market. Market players primarily focus on the development and launch of innovative clot management products, and inorganic strategies such as mergers and acquisitions in order to ensure their growth in this market.
Scope of the Report
This report categorizes the clot management market into the following segments and sub-segments:
Clot Management Market, by Product
Clot Management Market, by End User
Clot Management Market, by Region
Benchmarking the rapid strategy shifts of the Top 100 companies in the Clot Management MarketRequest For Special Pricing